granisetron has been researched along with Neoplasm Metastasis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chow, E; DeAngelis, C; Hunyh, L; McDonald, R; Pasetka, M; Raman, S; Rowbottom, L | 1 |
Hosaka, M; Kondoh, K; Kubota, Y; Masuda, M; Misaki, H; Noguchi, S; Sakuramoto, T; Shuin, T; Yao, M | 1 |
Baron, PL; Cole, DJ; Maize, JC; McClay, EF; McClay, ME; Metcalf, JS; Monroe, L; O'Brien, PH | 1 |
2 trial(s) available for granisetron and Neoplasm Metastasis
Article | Year |
---|---|
[M-VAC chemotherapy for advanced urothelial cancer--side effects and their management].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Colony-Stimulating Factors; Doxorubicin; Female; Gastrointestinal Diseases; Granisetron; Humans; Kidney Neoplasms; Kidney Pelvis; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neutropenia; Recombinant Proteins; Ureteral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms; Vinblastine | 1994 |
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Granisetron; Humans; Life Tables; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Neoplasm Staging; Ondansetron; Prognosis; Risk; Skin Neoplasms; Survival Analysis; Tamoxifen; Treatment Outcome; Vomiting | 2000 |
1 other study(ies) available for granisetron and Neoplasm Metastasis
Article | Year |
---|---|
Efficacy of granisetron and aprepitant in a patient who failed ondansetron in the prophylaxis of radiation induced nausea and vomiting: a case report.
Topics: Antiemetics; Aprepitant; Bone Neoplasms; Breast Neoplasms; Female; Granisetron; Humans; Middle Aged; Morpholines; Nausea; Neoplasm Metastasis; Ondansetron | 2015 |